Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company.

Our multi-target Bacterial Vector therapy platform, based on genetically modified lactic bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers - Cancers - Ovarian, Peritoneal


Hochbergerstrasse 60C, 4057 Basel, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business